Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury.
about
Receptor for advanced glycation end products and its involvement in inflammatory diseasesThe receptor for advanced glycation end-products supports lung tissue biomechanics.Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndromeThe receptor for advanced glycation end products (RAGE) and the lung.Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsisLack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in miceShort-term glutamine supplementation decreases lung inflammation and the receptor for advanced glycation end-products expression in direct acute lung injury in mice.Contribution of damage-associated molecular patterns to transfusion-related acute lung injury in cardiac surgery.Vagus nerve through α7 nAChR modulates lung infection and inflammation: models, cells, and signalsAlveolar fluid clearance is faster in women with acute lung injury compared to men.Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.Associations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants.The receptor for advanced glycation end products (RAGE) contributes to the progression of emphysema in micePolymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome.Leukemia inhibitory factor signaling is required for lung protection during pneumoniaRAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease.Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis.Participation of the receptor for advanced glycation end products in efferocytosis.The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine.Growth factors and cytokines in acute lung injury.Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury.Foxp3+ Regulatory T Cell Expression of Keratinocyte Growth Factor Enhances Lung Epithelial Proliferation.Primary graft dysfunction: pathophysiology to guide new preventive therapies.Interplay between RAGE, CD44, and focal adhesion molecules in epithelial-mesenchymal transition of alveolar epithelial cells.Anti-inflammatory functions of protein C require RAGE and ICAM-1 in a stimulus-dependent manner.Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: a case-cohort study and murine model of acute particulate exposureFoxp3+ regulatory T cells promote lung epithelial proliferation.Priming with endotoxin increases acute lung injury in mice by enhancing the severity of lung endothelial injury.Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study.Hydrogen Peroxide Stimulates Exosomal Cathepsin B Regulation of the Receptor for Advanced Glycation End-Products (RAGE).Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway.RAGE-induced changes in the proteome of alveolar epithelial cells.RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation.Association of five genetic variants with chronic obstructive pulmonary disease susceptibility and spirometric phenotypes in a Chinese Han population.
P2860
Q21285070-4FBD3D4D-1C1D-4231-BF9A-F2603072E009Q30317727-5FF7B2B3-E033-4C52-8757-912C1044A3CBQ30410928-02D3800E-6B46-4FBC-BD28-9226C8F0ED3DQ33632775-30237471-E2B7-40A3-B0D7-86E5A22E2772Q33633330-29984C85-2D59-4C47-A089-C9467EF66894Q33709127-CC857B48-381B-4657-9103-6FC770EB58E6Q33918403-B7DFB7C0-4B53-4711-A473-8B56BEC328E6Q33945173-ED0F2528-3D31-4C5F-9F1B-8EB878687B94Q33953460-56F08803-C5B3-418F-AA2B-9EE58553185EQ34022416-CF2E2D78-D96B-4190-B0B4-000E5C6F3E72Q34316213-B7026D50-A057-4404-89B0-B4D3F1B0CBCCQ34784921-CD90B66B-6A76-4986-9505-D4906603CF23Q35064231-14B29D65-FC5C-49EA-AE1D-8CA34F2B76A1Q35190905-A1E1B121-64B1-4600-AFE8-A52CB3C657ABQ35523593-DAEAF199-1FC2-4950-A524-DF070D98E318Q36016336-70DC831F-E461-418D-9B96-628301065CD7Q36193793-DB7FE78D-F8EE-45C0-B27C-65B1CFCFDF58Q37387418-933382E9-A12B-44E4-9B56-9ECCEEDEC423Q37638952-A6568C40-2891-46D8-AA6C-EA2BF0767CAFQ37815488-BDEA9B4C-23B1-4C3E-9F00-2E372F70E530Q38112030-AD5BF0FD-FB1E-4EBE-AB13-EC4C1D17E732Q38277156-CC428307-4EF8-41FC-BB27-ACEA72E1ED66Q38906242-3693C76C-570B-47F4-83C4-4EFF62C49E9FQ39027739-0B7011D5-08A9-47EA-A066-D28ADA1A2C9FQ39600783-1ABBD560-98FB-4EBF-B69F-36AD7904E864Q39699312-D3D64F57-64A1-4636-9164-C39D474A9906Q41571383-EF0D0D23-868B-4E9D-A731-EBE5CA4770BBQ41838208-8B697EBC-66FC-4912-A0FF-6CC1E97126AEQ42712136-FFB0337F-776B-4FA0-A2F1-2313F740FB71Q42794385-3D3F0053-7B5C-4C25-99B6-33B61DB5C8D8Q47390127-60EDFCF0-CBDD-4387-9BB0-CEE8C238A119Q48272114-DA04DAD6-4EDF-4581-9D38-A7B3371E9296Q49472978-3F077BFD-DE36-4C16-9C5A-E4FB2E3C4EFCQ49968796-31666942-5FAA-49B2-8631-D1AFC4CD9735Q51793428-4F7E1DE5-213F-4A40-B0CF-FBBFDFD5935AQ54522045-8E24C6AE-CC79-48A9-8082-5CE2288A0245
P2860
Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Receptor for advanced glycatio ...... s of experimental lung injury.
@en
Receptor for advanced glycation end-products
@nl
type
label
Receptor for advanced glycatio ...... s of experimental lung injury.
@en
Receptor for advanced glycation end-products
@nl
prefLabel
Receptor for advanced glycatio ...... s of experimental lung injury.
@en
Receptor for advanced glycation end-products
@nl
P2093
P2860
P1476
Receptor for advanced glycatio ...... s of experimental lung injury.
@en
P2093
Mark R Looney
Naveen Gupta
P2860
P356
10.1152/AJPLUNG.90546.2008
P577
2009-05-01T00:00:00Z